{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:12:59Z","timestamp":1792059179704,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.parkreldis.2015.02.025","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T05:52:56Z","timestamp":1425621176000},"page":"514-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Randomized, controlled pilot trial of solifenacin succinate for\u00a0overactive bladder in Parkinson's disease"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-1666","authenticated-orcid":false,"given":"Theresa A.","family":"Zesiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Evatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille P.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israt","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Ordorica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0380-9289","authenticated-orcid":false,"given":"Jessica D.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2015.02.025_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.archger.2008.11.006","article-title":"The burden of Parkinson disease (PD) and concomitant comorbidities","volume":"49","author":"Pohar","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib2","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.68.4.429","article-title":"Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score","volume":"68","author":"Araki","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0004-282X2003000300007","article-title":"Urinary symptoms in Parkinson's disease: prevalence and associated factors","volume":"61","author":"Campos-Sousa","year":"2003","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0090-4295(00)00641-5","article-title":"Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease","volume":"56","author":"Lemack","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mds.20867","article-title":"Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management","volume":"21","author":"Winge","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.eururo.2010.11.040","article-title":"Antimuscarinic mechanisms and the overactive detrusor: an update","volume":"59","author":"Andersson","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/nau.22602","article-title":"Urinary incontinence in frail elderly persons: report from the 5th international consultation on incontinence","author":"Wagg","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1464-410X.2009.08846.x","article-title":"Reliability and normal ranges for the patient's perception of intensity of urgency scale in asymptomatic women","volume":"105","author":"Cartwright","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.61.1.70","article-title":"Quality of life in patients with Parkinson's disease: development of a questionnaire","volume":"61","author":"de Boer","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0090-4295(98)00454-3","article-title":"Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL)","volume":"53","author":"Patrick","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib14","first-page":"153","article-title":"UPDRS program members. Unified Parkinsons disease rating scale","volume":"vol. 2","author":"Fahn","year":"1987"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/1082-989X.7.1.105","article-title":"Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs","volume":"7","author":"Morris","year":"2002","journal-title":"Psychol Methods"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.2044-8317.1988.tb00901.x","article-title":"Synthesizing standardized mean change measures","volume":"41","author":"Becker","year":"1988","journal-title":"Br J Math Stat Psychol"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib17","series-title":"Proceedings of the Annual Southeast SAS Users Group Conference","article-title":"A\u00a0SAS macro to compute effect size (Cohen's d) and its confidence interval from raw survey data","author":"Kadel","year":"2012"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/nau.20193","article-title":"Prevalence of bladder dysfunction in Parkinson disease","volume":"25","author":"K1","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.0b013e3181d55f24","article-title":"Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"74","author":"Zesiewicz","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.parkreldis.2015.02.025_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00702-012-0914-8","article-title":"Urological problems in Parkinson's disease: clinical aspects","volume":"120","author":"Jost","year":"2013","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2013.01.002","article-title":"Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study","volume":"64","author":"Wagg","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.parkreldis.2015.02.025_bib23","first-page":"1640","article-title":"Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms","volume":"164","author":"Araki","year":"2000","journal-title":"J\u00a0Urol"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T12:28:43Z","timestamp":1537792123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1353802015000802"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.025","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, controlled pilot trial of solifenacin succinate for\u00a0overactive bladder in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}